UK markets closed

ME Jan 2025 5.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.05000.0000 (0.00%)
As of 09:31AM EDT. Market open.
Full screen
Previous close0.0500
Open0.0500
Bid0.0000
Ask0.1000
Strike5.00
Expiry date2025-01-17
Day's range0.0500 - 0.0500
Contract rangeN/A
Volume25
Open interest2.41k
  • GlobeNewswire

    23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel

    SOUTH SAN FRANCISCO, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading preventive health and therapeutics company, and Nightingale Health Plc, a pioneer in biomarker testing and risk prediction, today announced a strategic collaboration to pilot Nightingale Health’s clinically-validated and cost-effective blood metabolomics panel with a cohort of 23andMe members. Nightingale’s Remote Health Check accurately measures dozens of biomarkers from a single blood sam

  • The Guardian

    Genetic testing company 23andMe investigated over hack that hit 7m users

    Data watchdogs in UK and Canada to look at whether there were enough safeguards on personal information

  • GlobeNewswire

    23andMe Launches New Genetic Report on Bipolar Disorder

    Provides 23andMe+ Premium members with insight into their likelihood of developing the serious mental health illness based on thousands of genetic variantsSOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, today released a new genetic Bipolar Disorder report (Powered by 23andMe Research) for 23andMe+ Premium members, informing them if they are at higher likelihood for being diagnosed with the co